Skip to content

Author

Ya-Bing Zhang

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Efficacy of two programmed cell death 1 combination regimens in recurrent and/or metastatic head and neck carcinoma: A real-world retrospective study

BACKGROUND The combination of programmed cell death 1 (PD-1) inhibitors with molecularly targeted agents, including anti-epidermal growth factor receptor monoclonal antibody (cetuximab) and multi-targeted tyrosine kinase inhibitor (such as anlotinib), has emerged as promising therapeutic strategies in recurrent and/or...

Jia-Xin Wang, Tian-Xiao Wang, Yun-Tao Song et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.